SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-05-003591
Filing Date
2005-08-09
Accepted
2005-08-09 14:50:28
Documents
7
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. w11762e10vq.htm 10-Q 232634
2 EX-10.1 w11762exv10w1.htm EX-10.1 216126
3 EX-31.1 w11762exv31w1.htm EX-31.1 8418
4 EX-31.2 w11762exv31w2.htm EX-31.2 8418
5 EX-32.1 w11762exv32w1.htm EX-32.1 3345
6 EX-32.2 w11762exv32w2.htm EX-32.2 3356
7 GRAPHIC w11762w1176277.gif GRAPHIC 24357
  Complete submission text file 0000950133-05-003591.txt   507382
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 051009241
SIC: 2836 Biological Products, (No Diagnostic Substances)